argenx reports fourth quarter business update and full year 2017 financial results
Management to host conference call today at 3 pm CET / 9 am EST March 1, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based …